Valion Bio Inc.
VBIO | NASDAQ
$0.53
-$0.02 (-3.64%)
Nov 2, 2026, 1:37 PM ET · Market open
Market Data
Market Cap $1.11M
Enterprise Value $16.45M
Beta 1.80
Average Volume 1.4M
Shares Outstanding (Diluted) 135.2K
Shares Change YoY -84.66%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US9189422028
Price Performance
Price Change 1M -79.5%
Price Change 3M -93.3%
Price Change 6M -98.0%
Price Change YTD -98.5%
Price Change 1Y -99.1%
Price Change 3Y -99.9%
Price Change 5Y N/A
1M CAGR (ann.) -74.1%
1Y CAGR (ann.) -99.1%
5Y CAGR (ann.) N/A
All-Time CAGR -92.5%
Valuation
PE Ratio -0.00
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio -7.39
Forward PS N/A
PB Ratio 0.10
P/FCF Ratio -0.08
P/Adj. FCF Ratio -0.08
P/OCF Ratio -0.01
EV/Sales -105.47
EV/EBIT -1.01
EV/EBITDA -1.06
EV/FCF -1.12
Earnings Yield -20358.2%
FCF Yield -1273.1%
Adj. FCF Yield -1316.1%
Financial Health
Net Debt $5.81M
Total Debt $17.41M
Cash & Short-Term Investments $2.11M
Total Assets $32.47M
Current Ratio 1.11
Quick Ratio 0.86
Debt / Equity Ratio 1.46
Debt / EBITDA -1.12
Debt / FCF -1.19
OCF / Debt -0.84
Interest Coverage -12.33
Altman Z-Score -4.49
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 516.0%
Operating Profit Margin 10587.2%
EBITDA Margin 9972.4%
Net Profit Margin 12019.2%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue -317.9%
SBC Impact (per share) -3.4%
Returns
Return on Assets -57.7%
Return on Equity -165.4%
Return on Invested Capital -55.1%
Return on Capital Employed -56.1%
Return on Tangible Assets -70.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -141.1%
Revenue CAGR 5Y -52.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -22.1%
EPS CAGR 5Y 78.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y -57.9%
FCF CAGR 5Y -11.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-14.58M
Free Cash Flow $-14.67M
Adj. Free Cash Flow $-15.17M
FCF Per Share -$108.54
OCF Per Share -$107.80
OCF/S Ratio 9342.9%
Income Statement
Revenue $-156K
Gross Profit $-805K
Operating Income $-16.52M
EBITDA $-15.56M
Net Income $-18.75M
EPS (Diluted) -$111.97
Revenue / Employee $-3K
Profit / Employee $-360.58K
Employees 52
Add to Watchlist
Select watchlists to add or remove VBIO